Pfizer Shares Drop Most in Decade After Mylan Deal, Weak Outlook

(Bloomberg) -- Pfizer Inc. shares took their largest drop in more than a decade, a day after announcing plans to combine its unit selling aging blockbuster drugs such as Lipitor and Viagra with gen...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.